Bayforest Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$980K	Buy	56,639 +4,301	+8%	+$74.5K	0.43%	38
2025 Q1	$1.14M	Buy	52,338 +42,499	+432%	+$929K	0.5%	21
2024 Q4	$314K	Buy	+9,839	New	+$314K	0.39%	33